Mythili Shastry
- Oncology top 5%
- Molecular Biology
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Erika HamiltonSandra M. SwainDenise A. YardleyJohn D. HainsworthHoward A. BurrisSaya JacobHope S. RugoS. Michelle Shiller
- Topics
- Cancer Treatment and Pharmacology (23 papers)HER2/EGFR in Cancer Research (22 papers)Advanced Breast Cancer Therapies (13 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Mythili Shastry
36 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 706
- Molecular Biology 396
- Cancer Research 291
- Radiology, Nuclear Medicine and Imaging 285
- Pulmonary and Respiratory Medicine 235
Countries citing papers authored by Mythili Shastry
This map shows the geographic impact of Mythili Shastry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mythili Shastry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mythili Shastry more than expected).
Fields of papers citing papers by Mythili Shastry
This network shows the impact of papers produced by Mythili Shastry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mythili Shastry. The network helps show where Mythili Shastry may publish in the future.
Co-authorship network of co-authors of Mythili Shastry
This figure shows the co-authorship network connecting the top 25 collaborators of Mythili Shastry. A scholar is included among the top collaborators of Mythili Shastry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mythili Shastry. Mythili Shastry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | Targeting HER2-positive breast cancer: advances and future directionsbreakdown → | 583 |
| 4 | 81 | |
| 5 | 9 | |
| 6 | 76 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 6 | |
| 10 | 21 | |
| 11 | 41 | |
| 12 | 12 | |
| 13 | 7 | |
| 14 | 88 | |
| 15 | 14 | |
| 16 | 45 | |
| 17 | 38 | |
| 18 | 42 | |
| 19 | 4 | |
| 20 | 17 |
About Mythili Shastry
Mythili Shastry is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (23 papers), HER2/EGFR in Cancer Research (22 papers) and Advanced Breast Cancer Therapies (13 papers). The work is most often cited by research in Oncology (706 citations), Cancer Research (291 citations) and Radiology, Nuclear Medicine and Imaging (285 citations). Mythili Shastry has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Erika Hamilton, Sandra M. Swain, Denise A. Yardley, John D. Hainsworth, Howard A. Burris, Saya Jacob, Hope S. Rugo, S. Michelle Shiller, Rongqin Ren and Kent C. Shih. Their work appears in journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.